Lisa Kuhns, PhD, MD

News

Activated Platelet Rich Plasma Improves Alopecia

04/20/2023

Lisa Kuhns , PhD, MD;

Researchers aimed to assess the clinical efficacy and safety of autologous A-PRP injections in patients with alopecia.

Researchers aimed to assess the...

04/20/2023

The Dermatologist

News

A Metropolitan Monitoring Framework Proposed to Track Opioids in Wastewater

12/15/2023

Lisa Kuhns , PhD, MD;

A new innovative approach for monitoring opioid use and analyzing trends by utilizing wastewater-based epidemiologic methods may help public health officials worldwide manage the opioid epidemic in large metro areas, according to a study...

A new innovative approach for...

12/15/2023

Pharmacy Learning Network

News

Neurostimulation Produces a Stable Quality of Life Up to 5 Years in Patients With Parkinson Disease, Study Finds

05/08/2024

Lisa Kuhns , PhD, MD;

Deep brain stimulation of the subthalamic nucleus (STN-DBS) results in a stable quality of life (QOL) over 5 years in patients with advanced Parkinson disease, according to a study published in JAMA Network Open.

Deep brain stimulation of the...

05/08/2024

Annals of Long-Term Care

News

Health Care Burden Increases With Psoriasis Severity in Pediatric Patients

06/24/2021

Lisa Kuhns , PhD, MD;

A recent study demonstrated an increase in health care use and costs with psoriasis severity for pediatric patients.

A recent study demonstrated an...

06/24/2021

The Dermatologist

News

Increased Air Pollution Linked to AD and Chronic Inflammatory Skin Diseases

09/24/2021

Lisa Kuhns , PhD, MD;

According to a study published in Clinical and Experimental Dermatology, particulate matter (PM) is associated with atopic dermatitis (AD) and chronic inflammatory skin diseases in South Korea. Researchers aimed to investigate the...

According to a study published...

09/24/2021

The Dermatologist

News

Risankizumab Safe and Effective for Patients With Moderate to Severe Plaque Psoriasis Throughout a 52-Week Period

10/19/2022

Lisa Kuhns , PhD, MD;

Researchers aimed to assess the real-life effectiveness and safety of risankizumab.

Researchers aimed to assess the...

10/19/2022

The Dermatologist

News

Predicting the Survival of Patients With Head and Neck Squamous Cell Carcinoma

03/03/2023

Lisa Kuhns , PhD, MD;

An identified 9-gene prognostic signature based on the lysine regulators might contribute to prognosis stratification and treatment escalation for patients with head and neck squamous cell carcinoma.

An identified 9-gene prognostic...

03/03/2023

The Dermatologist

News

Analytical Methods Used by the FDA for Drug Approvals in 2023

10/05/2023

Lisa Kuhns , PhD, MD;

Utilizing robust and diverse analytical methods in 2023, the FDA ensured rigorous assessment of drug quality, safety, and efficacy in drug approval, providing reliable and effective treatments for patients, according to a study published in...

Utilizing robust and diverse...

10/05/2023

Pharmacy Learning Network

News

Florida Surgeon General Flags DNA Integration Risks in Pfizer and Moderna COVID-19 Vaccines, Urges FDA Action

01/24/2024

Lisa Kuhns , PhD, MD;

State Surgeon General Dr Joseph A. Ladapo sent a letter to the United States Food and Drug Administration (FDA) Commissioner Dr Robert M. Califf and Center for Disease Control and Prevention (CDC) Director Dr Mandy Cohen regarding questions...

State Surgeon General Dr Joseph...

01/24/2024

Integrated Healthcare Executive

News

Gender, Race, Health, and Limitation Status May Help Target Interventions to Increase Physical Activity Among Patients With Asthma

12/08/2023

Lisa Kuhns , PhD, MD;

Targeted interventions to increase physical activity among US adults with asthma may benefit from considering gender, race, health status, and limitation status, according to a study published in the Journal of Asthma.

Targeted interventions to...

12/08/2023

First Report Managed Care